Facial Rejuvenation Market Research Report - Global Forecast till 2027

Facial Rejuvenation Market Research Report: By Product Type (Botulinum Toxin, Dermal Fillers, Chemical Peels, Topical Skin Care Products, Skin Rejuvenation Devices) and By End-User (Hospitals and Clinics, Dermatology Clinics, Others) – Forecast to 2027

ID: MRFR/HC/7339-HCR | August 2022 | Region: Global | 90 Pages         

Table of Contents

1. REPORT PROLOGUE

2. MARKET INTRODUCTION

2.1. Definition

2.2. Scope of the Study

2.2.1. Research Objective

2.2.2. Assumptions

2.2.3. Limitations

3. RESEARCH METHODOLOGY

3.1. Overview

3.2. Primary Research

3.3. Secondary Research

3.4. Market Size Estimation

4. MARKET DYNAMICS

4.1. Overview

4.2. Drivers

4.3. Restraints

4.4. Opportunities

5. MARKET FACTOR ANALYSIS

5.1. Porter’s Five Forces Analysis

5.1.1. Bargaining Power of Suppliers

5.1.2. Bargaining Power of Buyers

5.1.3. Threat of New Entrants

5.1.4. Threat of Substitutes

5.1.5. Intensity of Rivalry

5.2. Value Chain Analysis 

6. GLOBAL FACIAL REJUVENATION MARKET, BY PRODUCT TYPE

6.1. Overview

6.2. Botulinum Toxin

Market Estimates & Forecast, by Region, 2020-2027

Market Estimates & Forecast, by Country, 2020-2027

6.3. Dermal Fillers

Market Estimates & Forecast, by Region, 2020-2027

Market Estimates & Forecast, by Country, 2020-2027

6.3.1. Hyaluronic Acid

Market Estimates & Forecast, by Region, 2020-2027

Market Estimates & Forecast, by Country, 2020-2027

6.3.2. Polymers & Particles

Market Estimates & Forecast, by Region, 2020-2027

Market Estimates & Forecast, by Country, 2020-2027

6.3.3. Calcium Hydroxyapatite

Market Estimates & Forecast, by Region, 2020-2027

Market Estimates & Forecast, by Country, 2020-2027

6.3.4. Collagen

Market Estimates & Forecast, by Region, 2020-2027

Market Estimates & Forecast, by Country, 2020-2027

6.4. Chemical Peels

Market Estimates & Forecast, by Region, 2020-2027

Market Estimates & Forecast, by Country, 2020-2027

6.5. Topical Skin Care Products

Market Estimates & Forecast, by Region, 2020-2027

Market Estimates & Forecast, by Country, 2020-2027

6.6. Skin Rejuvenation Devices

Market Estimates & Forecast, by Region, 2020-2027

Market Estimates & Forecast, by Country, 2020-2027

6.6.1. Intense Pulsed Light

Market Estimates & Forecast, by Region, 2020-2027

Market Estimates & Forecast, by Country, 2020-2027

6.6.2. Microdermabrasion

Market Estimates & Forecast, by Region, 2020-2027

Market Estimates & Forecast, by Country, 2020-2027

6.6.3. Laser-based Devices

Market Estimates & Forecast, by Region, 2020-2027

Market Estimates & Forecast, by Country, 2020-2027

6.6.4. Ultrasound

Market Estimates & Forecast, by Region, 2020-2027

Market Estimates & Forecast, by Country, 2020-2027

7. GLOBAL FACIAL REJUVENATION MARKET, BY END USER

7.1. Overview

7.2. Hospitals and Clinics

Market Estimates & Forecast, by Region, 2020-2027

Market Estimates & Forecast, by Country, 2020-2027

7.3. Dermatology Clinics

Market Estimates & Forecast, by Region, 2020-2027

Market Estimates & Forecast, by Country, 2020-2027

7.4. Others

Market Estimates & Forecast, by Region, 2020-2027

Market Estimates & Forecast, by Country, 2020-2027

8. GLOBAL FACIAL REJUVENATION MARKET, BY REGION

8.1. Overview

8.2. Americas

8.2.1. North America

8.2.1.1. US

8.2.1.2. Canada

8.2.2. Latin America

8.3. Europe

8.3.1. Western Europe

8.3.1.1. Germany

8.3.1.2. France

8.3.1.3. Italy

8.3.1.4. Spain

8.3.1.5. UK

8.3.1.6. Rest of Western Europe

8.3.2. Eastern Europe

8.4. Asia-Pacific

8.4.1. Japan

8.4.2. China

8.4.3. India

8.4.4. Australia

8.4.5. South Korea

8.4.6. Rest of Asia-Pacific

8.5. Middle East & Africa

8.5.1. Middle East

8.5.2. Africa

9. COMPANY LANDSCAPE

9.1. Overview

9.2. Competitive Analysis

9.3. Market Share Analysis

9.4. Major Growth Strategy in the Global Facial Rejuvenation Market

9.5. Competitive Benchmarking

9.6. Leading Players in terms of Number of Developments in the Global Facial Rejuvenation Market

9.7. Key developments and Growth Strategies

9.7.1. New Product Launch/Service Deployment

9.7.2. Merger & acquisitions

9.7.3. Joint Ventures

9.8. Major Players Financial Matrix & Market Ratio

9.8.1. Sales & Operating Income 2018

9.8.2. Major Players R&D Expenditure 2018

9.9. Major Players Capital Market Ratio

10. COMPANY PROFILES

10.1. Allergan

10.1.1. Company Overview

10.1.2. Product Overview

10.1.3. Financial Overview

10.1.4. Key Developments

10.1.5. SWOT Analysis

10.1.6. Key Strategies

10.2. Merz Pharma

10.2.1. Company Overview

10.2.2. Product Overview

10.2.3. Financial Overview

10.2.4. Key Developments

10.2.5. SWOT Analysis

10.2.6. Key Strategies

10.3. Galderma

10.3.1. Company Overview

10.3.2. Product Overview

10.3.3. Financial Overview

10.3.4. Key Developments

10.3.5. SWOT Analysis

10.3.6. Key Strategies

10.4. Lumenis

10.4.1. Company Overview

10.4.2. Product Overview

10.4.3. Financial Overview

10.4.4. Key Developments

10.4.5. SWOT Analysis

10.4.6. Key Strategies

10.5. Revance

10.5.1. Company Overview

10.5.2. Product Overview

10.5.3. Financial Overview

10.5.4. Key Developments

10.5.5. SWOT Analysis

10.5.6. Key Strategies

10.6. Contura Ltd

10.6.1. Company Overview

10.6.2. Product Overview

10.6.3. Financial Overview

10.6.4. Key Developments

10.6.5. SWOT Analysis

10.6.6. Key Strategies

10.7. Anika Therapeutics, Inc.

10.7.1. Company Overview

10.7.2. Product Overview

10.7.3. Financial Overview

10.7.4. Key Developments

10.7.5. SWOT Analysis

10.7.6. Key Strategies

10.8. Fibrocell Science, Inc.

10.8.1. Company Overview

10.8.2. Product Overview

10.8.3. Financial Overview

10.8.4. Key Developments

10.8.5. SWOT Analysis

10.8.6. Key Strategies

10.9. Cynosure, A Hologic Company

10.9.1. Company Overview

10.9.2. Product Overview

10.9.3. Financial Overview

10.9.4. Key Developments

10.9.5. SWOT Analysis

10.9.6. Key Strategies

10.10. Daewoong Co. Ltd

10.10.1. Company Overview

10.10.2. Product Overview

10.10.3. Financial Overview

10.10.4. Key Developments

10.10.5. SWOT Analysis

10.10.6. Key Strategies

10.11. Sinclair Pharma

10.11.1. Company Overview

10.11.2. Product Overview

10.11.3. Financial Overview

10.11.4. Key Developments

10.11.5. SWOT Analysis

10.11.6. Key Strategies

10.12. Teoxane Laboratories

10.12.1. Company Overview

10.12.2. Product Overview

10.12.3. Financial Overview

10.12.4. Key Developments

10.12.5. SWOT Analysis

10.12.6. Key Strategies

10.13. Suneva Medical

10.13.1. Company Overview

10.13.2. Product Overview

10.13.3. Financial Overview

10.13.4. Key Developments

10.13.5. SWOT Analysis

10.13.6. Key Strategies

10.14. Solta Medical, a Subsidiary of Bausch Health Companies

10.14.1. Company Overview

10.14.2. Product Overview

10.14.3. Financial Overview

10.14.4. Key Developments

10.14.5. SWOT Analysis

10.14.6. Key Strategies

10.15. SciVision Biotech, Inc.

10.15.1. Company Overview

10.15.2. Product Overview

10.15.3. Financial Overview

10.15.4. Key Developments

10.15.5. SWOT Analysis

10.15.6. Key Strategies

10.16. Others

11. APPENDIX

11.1. References

11.2. Related Reports

NOTE:

This table of content is tentative and subject to change as the research progresses.

• In section 10, major 10 companies will be profiled. Each company will be profiled based on the Market Overview, Financials, Product Portfolio, Business Strategies, and Recent Developments parameters.

• Please note: The financial details of the company cannot be provided if the information is not available in the public domain and or from reliable sources. 

LIST OF TABLES

TABLE 1 GLOBAL FACIAL REJUVENATION MARKET SYNOPSIS, 2020-2027

TABLE 2 GLOBAL FACIAL REJUVENATION MARKET ESTIMATES & FORECAST, 2020-2027 (USD MILLION)

TABLE 3 GLOBAL FACIAL REJUVENATION MARKET, BY PRODUCT TYPE, 2020-2027 (USD MILLION)

TABLE 4 GLOBAL FACIAL REJUVENATION MARKET, BY END USER, 2020-2027 (USD MILLION)

TABLE 5 GLOBAL FACIAL REJUVENATION MARKET, BY REGION, 2020-2027 (USD MILLION)

TABLE 6 NORTH AMERICA: FACIAL REJUVENATION MARKET, BY PRODUCT TYPE, 2020-2027 (USD MILLION)

TABLE 7 NORTH AMERICA: FACIAL REJUVENATION MARKET, BY END USER, 2020-2027 (USD MILLION)

TABLE 8 US: FACIAL REJUVENATION MARKET, BY PRODUCT TYPE, 2020-2027 (USD MILLION)

TABLE 9 US: FACIAL REJUVENATION MARKET, BY END USER, 2020-2027 (USD MILLION)

TABLE 10 CANADA: FACIAL REJUVENATION MARKET, BY PRODUCT TYPE, 2020-2027 (USD MILLION)

TABLE 11 CANADA: FACIAL REJUVENATION MARKET, BY END USER, 2020-2027 (USD MILLION)

TABLE 12 LATIN AMERICA: FACIAL REJUVENATION MARKET, BY PRODUCT TYPE, 2020-2027 (USD MILLION)

TABLE 13 LATIN AMERICA: FACIAL REJUVENATION MARKET, BY END USER, 2020-2027 (USD MILLION)

TABLE 14 EUROPE: FACIAL REJUVENATION MARKET, BY PRODUCT TYPE, 2020-2027 (USD MILLION)

TABLE 15 EUROPE: FACIAL REJUVENATION MARKET, BY END USER, 2020-2027 (USD MILLION)

TABLE 16 WESTERN EUROPE: FACIAL REJUVENATION MARKET, BY PRODUCT TYPE, 2020-2027 (USD MILLION)

TABLE 17 WESTERN EUROPE: FACIAL REJUVENATION MARKET, BY END USER, 2020-2027 (USD MILLION)

TABLE 18 EASTERN EUROPE: FACIAL REJUVENATION MARKET, BY PRODUCT TYPE, 2020-2027 (USD MILLION)

TABLE 19 EASTERN EUROPE: FACIAL REJUVENATION MARKET, BY END USER, 2020-2027 (USD MILLION)

TABLE 20 ASIA-PACIFIC: FACIAL REJUVENATION MARKET, BY PRODUCT TYPE, 2020-2027 (USD MILLION)

TABLE 21 ASIA-PACIFIC: FACIAL REJUVENATION MARKET, BY END USER, 2020-2027 (USD MILLION)

TABLE 22 MIDDLE EAST & AFRICA: FACIAL REJUVENATION MARKET, BY PRODUCT TYPE, 2020-2027 (USD MILLION)

TABLE 23 MIDDLE EAST & AFRICA: FACIAL REJUVENATION MARKET, BY END USER, 2020-2027 (USD MILLION)


LIST OF FIGURES

FIGURE 1 RESEARCH PROCESS

FIGURE 2 MARKET STRUCTURE FOR THE GLOBAL FACIAL REJUVENATION MARKET

FIGURE 3 MARKET DYNAMICS FOR THE GLOBAL FACIAL REJUVENATION MARKET

FIGURE 4 GLOBAL FACIAL REJUVENATION MARKET SHARE, BY PRODUCT TYPE, 2020(%)

FIGURE 5 GLOBAL FACIAL REJUVENATION MARKET SHARE, BY END USER, 2020(%)

FIGURE 6 GLOBAL FACIAL REJUVENATION MARKET SHARE, BY REGION, 2020(%)

FIGURE 7 AMERICAS: FACIAL REJUVENATION MARKET SHARE BY REGION, 2020(%)

FIGURE 7 NORTH AMERICA: FACIAL REJUVENATION MARKET SHARE, BY COUNTRY, 2020(%)

FIGURE 8 EUROPE: FACIAL REJUVENATION MARKET SHARE, BY REGION, 2020(%)

FIGURE 9 WESTERN EUROPE: FACIAL REJUVENATION MARKET SHARE, BY COUNTRY, 2020(%)

FIGURE 10 ASIA-PACIFIC: FACIAL REJUVENATION MARKET SHARE, BY COUNTRY, 2020(%)

FIGURE 11 MIDDLE EAST & AFRICA: FACIAL REJUVENATION MARKET SHARE, BY COUNTRY, 2020(%)

FIGURE 12 GLOBAL FACIAL REJUVENATION MARKET: COMPANY SHARE ANALYSIS, 2020(%)

FIGURE 13 ALLERGAN.: KEY FINANCIALS

FIGURE 14 ALLERGAN: SEGMENTAL REVENUE

FIGURE 15 ALLERGAN: REGIONAL REVENUE

FIGURE 16 MERZ PHARMA: KEY FINANCIALS

FIGURE 17 MERZ PHARMA: SEGMENTAL REVENUE

FIGURE 18 MERZ PHARMA: REGIONAL REVENUE

FIGURE 19 GALDERMA: KEY FINANCIALS

FIGURE 20 GALDERMA: SEGMENTAL REVENUE

FIGURE 21 GALDERMA: REGIONAL REVENUE

FIGURE 22 LUMENIS: KEY FINANCIALS

FIGURE 23 LUMENIS: SEGMENTAL REVENUE

FIGURE 24 LUMENIS: REGIONAL REVENUE

FIGURE 25 REVANCE: KEY FINANCIALS

FIGURE 26 REVANCE: SEGMENTAL REVENUE

FIGURE 27 DEPLOYMENT: REGIONAL REVENUE

FIGURE 28 CONTURA LTD: KEY FINANCIALS

FIGURE 29 CONTURA LTD: SEGMENTAL REVENUE

FIGURE 30 CONTURA LTD: REGIONAL REVENUE

FIGURE 31 ANIKA THERAPEUTICS, INC.: KEY FINANCIALS

FIGURE 32 ANIKA THERAPEUTICS, INC.: SEGMENTAL REVENUE

FIGURE 33 ANIKA THERAPEUTICS, INC.: REGIONAL REVENUE

FIGURE 34 FIBROCELL SCIENCE, INC.: KEY FINANCIALS

FIGURE 35 FIBROCELL SCIENCE, INC.: SEGMENTAL REVENUE

FIGURE 36 FIBROCELL SCIENCE, INC.: REGIONAL REVENUE

FIGURE 37 CYNOSURE, A HOLOGIC COMPANY: KEY FINANCIALS

FIGURE 38 CYNOSURE, A HOLOGIC COMPANY: SEGMENTAL REVENUE

FIGURE 39 CYNOSURE, A HOLOGIC COMPANY: REGIONAL REVENUE

FIGURE 40 DAEWOONG CO. LTD: KEY FINANCIALS

FIGURE 41 DAEWOONG CO. LTD: SEGMENTAL REVENUE

FIGURE 42 DAEWOONG CO. LTD: REGIONAL REVENUE

FIGURE 43 SINCLAIR PHARMA: KEY FINANCIALS

FIGURE 44 SINCLAIR PHARMA: SEGMENTAL REVENUE

FIGURE 45 SINCLAIR PHARMA: REGIONAL REVENUE

FIGURE 46 TEOXANE LABORATORIES: KEY FINANCIALS

FIGURE 47 TEOXANE LABORATORIES: SEGMENTAL REVENUE

FIGURE 48 TEOXANE LABORATORIES: REGIONAL REVENUE

FIGURE 49 SUNEVA MEDICAL: KEY FINANCIALS

FIGURE 50 SUNEVA MEDICAL: SEGMENTAL REVENUE

FIGURE 51 SUNEVA MEDICAL: REGIONAL REVENUE

FIGURE 52 SOLTA MEDICAL, A SUBSIDIARY OF BAUSCH HEALTH COMPANIES: KEY FINANCIALS

FIGURE 53 SOLTA MEDICAL, A SUBSIDIARY OF BAUSCH HEALTH COMPANIES: SEGMENTAL REVENUE

FIGURE 54 SOLTA MEDICAL, A SUBSIDIARY OF BAUSCH HEALTH COMPANIES: REGIONAL REVENUE

FIGURE 55 SCIVISION BIOTECH INC.: KEY FINANCIALS

FIGURE 56 SCIVISION BIOTECH INC.: SEGMENTAL REVENUE

FIGURE 57 SCIVISION BIOTECH INC.: REGIONAL REVENUE

Facial Rejuvenation Market

Facial rejuvenation market is expected to reach USD 27,110.43 Million at 20.65% CAGR by 2027.

Segmentation

By Product Type Botulinum Toxin Dermal Fillers Chemical Peels Topical Skin Care Products Skin Rejuvenation Devices
By End-User Hospitals And Clinics Dermatology Clinics

Key Players

  • Allergan (Ireland)
  • Merz Pharma (Germany)
  • Galderma (Switzerland)
  • Lumenis (US)
  • Revance (US)
  • Contura Ltd (US)
  • Anika Therapeutics Inc. (US)
  • Fibrocell Science Inc. (US)
  • Cynosure
  • A Hologic Company (US)

Drivers

  • Cost-effective alternative to cosmetic surgeries.
  • Rising demand for non-invasive aesthetic procedures.
  • Increasing R&D expenditure by companies to develop advanced treatments
Speak to Analyst Request a Free Sample

Market Synopsis


Facial rejuvenation market is expected to reach USD 27,110.43 Million at 20.65% CAGR by 2027. Facial rejuvenation is a type of cosmetic treatment that uses non-invasive or minimally invasive procedures to restore the skin elasticity and improve the appearance of the skin. Growing demand for non-invasive aesthetic procedures, technological advancements by market players and changing lifestyle of the urban population are the key factors that are expected to drive the market growth. Moreover, the rising demand for quick results & shorter treatment durations and increasing popularity & awareness regarding facial rejuvenation are also expected to boost market growth.


Facial Rejuvenation Market Influencer


The increasing popularity of facial rejuvenation over invasive cosmetic procedures is expected to increase the demand for procedures.


Facial Rejuvenation Market Drivers



  • Cost-effective alternative to cosmetic surgeries. In comparison to cosmetic surgeries, dermal fillers prove to be more reliable, affordable, and cost-effective. In 2018, the fees incurred by practitioners for facelift surgery was about USD 7,655, whereas, fees for facial rejuvenation using hyaluronic acid was just USD 682 in the US. This data demonstrates that fees of dermal fillers are quite low when compared to surgery, thus, increasing the preferability rates of dermal fillers.



  • Rising demand for non-invasive aesthetic procedures



  • Increasing R&D expenditure by companies to develop advanced treatments



  • Change in the lifestyle of the urban population



  • Rising demand for quick results and shorter treatment durations



  • Growing awareness and popularity regarding facial rejuvenation



  • Deeper penetration of cosmetic products in the local markets


Facial Rejuvenation Market Restraints



  • Side effects associated with dermal fillers

  • Lack of skilled professionals

  • Growing availability of fraudulent products

  • Lack of knowledge regarding product efficacy

  • Improper standardization of regulations


Facial Rejuvenation Market Segmentation


By Product Type



  • Botulinum Toxin: Increasing the number of product approvals and rising acceptance of botulinum toxin by consumers is expected to drive the market growth for the segment.



  • Dermal Fillers: This segment held the largest market share in 2018 owing to its growing demand globally, increasing use of dermal fillers by the cosmetic surgeons, and its cost-effectiveness over other alternatives. Dermal Fillers are further segmented into hyaluronic acid, polymers & particles, calcium hydroxyapatite, and collagen.



  • Chemical Peels: The rising popularity of chemical peels due to its regenerative effect on the skin is anticipated to drive the market growth.



  • Topical Skin Care Products: Easy accessibility and usage over other products is expected to drive the market growth



  • Skin Rejuvenation Devices: Technological advancements, wide adoption in the cosmetic industry, and long-lasting effects of the procedures are anticipated to drive the market growth. This segment is further segmented into intense pulsed light, microdermabrasion, laser-based devices, and ultrasound.


By End-User



  • Hospitals and Clinics: This segment is expected to grow significantly, owing to the rising patient population.



  • Dermatology Clinics: This segment is expected to demonstrate the fastest growth owing to its increasing popularity in developing countries.



  • Others: This includes research and academic instituted and beauty centers, among others.


By Region



  • Americas: The largest regional market. Increase in the number of minimally invasive cosmetic procedures, high per capita disposable income, and increasing awareness about procedures related to dermal fillers. For instance, in 2017, about 17.5 million surgical and minimally invasive cosmetic procedures were performed in the US, with a 2% increase in the number of procedures over 2016. Thus, the demand for facial rejuvenation procedures has been increasing in the region, hence driving the market growth.



  • Europe: The Facial Rejuvenation market in Europe held the second-largest position in 2018 owing to the increasing acceptance of new aesthetic products and the increasing number of product approvals & availability of products across the region.



  • Asia-Pacific: The fastest-growing regional market. The growth of the facial rejuvenation market in this region is owing to rising per capita disposable income, escalating demand of facial aesthetics products, and increasing awareness about non-invasive cosmetic procedures available in the market.



  • Middle East & Africa: The market is expected to show the lowest growth due to limited access to treatment facilities and limited developments in technology.


Facial Rejuvenation Market Key Players



  • Allergan (Ireland)

  • Merz Pharma (Germany)

  • Galderma (Switzerland)

  • Lumenis (US)

  • Revance (US)

  • Contura Ltd (US)

  • Anika Therapeutics, Inc. (US)

  • Fibrocell Science, Inc. (US)

  • Cynosure, A Hologic Company (US)

  • Daewoong Co. Ltd (South Korea)

  • Sinclair Pharma (UK)

  • Teoxane Laboratories (Switzerland)

  • Suneva Medical (US)

  • Solta Medical, a Subsidiary of Bausch Health Companies (US)

  • SciVision Biotech Inc. (Taiwan)



Report Scope:
Report Attribute/Metric Details
  Market Size   USD 27,110.43 Million
  CAGR   20.65% (2020-2027)
  Base Year   2019
  Forecast Period   2020-2027
  Historical Data   2018
  Forecast Units   Value (USD Million)
  Report Coverage   Revenue Forecast, Competitive Landscape, Growth Factors, and Trends
  Segments Covered   Product Type and By End-User
  Geographies Covered   North America, Europe, Asia-Pacific, and Rest of the World (RoW)
  Key Vendors   Allergan (Ireland), Merz Pharma (Germany), Galderma (Switzerland), Lumenis (US), Revance (US), Contura Ltd (US), Anika Therapeutics, Inc. (US), Fibrocell Science, Inc. (US), Cynosure, A Hologic Company (US), Daewoong Co. Ltd (South Korea), Sinclair Pharma (UK), Teoxane Laboratories (Switzerland), Suneva Medical (US), Solta Medical, a Subsidiary of Bausch Health Companies (US), and SciVision Biotech Inc. (Taiwan).
  Key Market Opportunities   The increasing popularity of facial rejuvenation over invasive cosmetic procedures is expected to increase the demand for procedures
  Key Market Drivers

  • Cost-effective alternative to cosmetic surgeries.
  • Rising demand for non-invasive aesthetic procedures.
  • Increasing R&D expenditure by companies to develop advanced treatments


  • Speak to Analyst Ask for Customization

    Frequently Asked Questions (FAQ) :

    The requirement for non-invasive aesthetic procedures is estimated to promote the global market.

    By 2027, the market is anticipated to observe 20.65% CAGR in the impending period.

    An income of USD 27,110.43 Million is to be expected to spur the market.

    The Americas regional market is estimated to gain a leadership position in the forecast period.

    Anika Therapeutics, Inc. (US), Galderma (Switzerland), Revance (US), Contura Ltd (US), Lumenis (US), and Fibrocell Science, Inc. (US) are the frontrunners in the market.